Mutability and hypermutation antagonize immunoglobulin codon optimality.

TitleMutability and hypermutation antagonize immunoglobulin codon optimality.
Publication TypeJournal Article
Year of Publication2025
AuthorsMcGrath JJC, Park J, Troxell CA, Chervin JC, Li L, Kent JR, Changrob S, Fu Y, Huang M, Zheng N-Y, G Wilbanks D, Nelson SA, Sun J, Inghirami G, Madariaga MLucia L, Georgiou G, Wilson PC
JournalMol Cell
Volume85
Issue2
Pagination430-444.e6
Date Published2025 Jan 16
ISSN1097-4164
KeywordsAnimals, Antibodies, Monoclonal, Codon, Complementarity Determining Regions, COVID-19, HIV-1, Humans, Immunoglobulin G, Immunoglobulin Heavy Chains, Immunoglobulin Variable Region, Mice, Mutation, SARS-CoV-2, Somatic Hypermutation, Immunoglobulin, V(D)J Recombination, Zebrafish
Abstract

The efficacy of antibody responses is inherently linked to paratope diversity, as generated through V(D)J recombination and somatic hypermutation. Despite this, it is unclear how genetic diversification mechanisms evolved alongside codon optimality and affect antibody expression. Here, we analyze germline immunoglobulin (IG) genes, natural V(D)J repertoires, serum IgG, and monoclonal antibody (mAb) expression through the lens of codon optimality. Germline variable genes (IGVs) exhibit diverse optimality that is inversely related to mutability. Hypermutation deoptimizes heavy-chain (IGH) VDJ repertoires within human tonsils, bone marrow, lymph nodes (including SARS-CoV-2-specific clones), blood (HIV-1-specific clones), mice, and zebrafish. Analyses of mutation-affected codons show that targeting to complementarity-determining regions constrains deoptimization. Germline IGHV optimality correlates with serum variable fragment (VH) usage after influenza vaccination, while synonymous deoptimization attenuated mAb yield. These findings provide unanticipated insights into an antagonistic relationship between diversification mechanisms and codon optimality. Ultimately, the need for diversity takes precedence over that for the most optimal codon usage.

DOI10.1016/j.molcel.2024.11.033
Custom 1

https://www.ncbi.nlm.nih.gov/pubmed/39708804?dopt=Abstract

Alternate JournalMol Cell
PubMed ID39708804
PubMed Central IDPMC12063209
Grant ListU19 AI168632 / AI / NIAID NIH HHS / United States
U01 AI153700 / AI / NIAID NIH HHS / United States
75N93019C00051 / AI / NIAID NIH HHS / United States
U01 AI165452 / AI / NIAID NIH HHS / United States
INV-004956 / GATES / Gates Foundation / United States
U01 AI144616 / AI / NIAID NIH HHS / United States
P01 AI165077 / AI / NIAID NIH HHS / United States
75N93021C00014 / AI / NIAID NIH HHS / United States

Weill Cornell Medicine Gale and Ira Drukier Institute for Children's Health 413 E. 69th Street New York, NY 10021